Michael W. Dunne
Pfizer Global Research & Development
New London
Connecticut 06320
USA
Name/email consistency: high
- A multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodium falciparum malaria in India. Dunne, M.W., Singh, N., Shukla, M., Valecha, N., Bhattacharyya, P.C., Dev, V., Patel, K., Mohapatra, M.K., Lakhani, J., Benner, R., Lele, C., Patki, K. J. Infect. Dis. (2005)
- Efficacy of single-dose azithromycin in treatment of acute otitis media in children after a baseline tympanocentesis. Dunne, M.W., Khurana, C., Mohs, A.A., Rodriguez, A., Arrieta, A., McLinn, S., Krogstad, J.A., Blatter, M., Schwartz, R., Vargas, S.L., Emparanza, P., Fernandez, P., Gooch, W.M., Aspin, M., Podgore, J., Roine, I., Blumer, J.L., Ehrlich, G.D., Chow, J. Antimicrob. Agents Chemother. (2003)
- Randomized, double-blind study of the clinical efficacy of 3 days of azithromycin compared with co-amoxiclav for the treatment of acute otitis media. Dunne, M.W., Latiolais, T., Lewis, B., Pistorius, B., Bottenfield, G., Moore, W.H., Garrett, A., Stewart, T.D., Aoki, J., Spiegel, C., Boettger, D., Shemer, A. J. Antimicrob. Chemother. (2003)